MENGA, ALESSIO
 Distribuzione geografica
Continente #
EU - Europa 4.636
NA - Nord America 1.425
AS - Asia 871
SA - Sud America 157
AF - Africa 90
Continente sconosciuto - Info sul continente non disponibili 59
OC - Oceania 2
Totale 7.240
Nazione #
NL - Olanda 3.749
US - Stati Uniti d'America 1.348
RU - Federazione Russa 447
SG - Singapore 325
CN - Cina 159
IT - Italia 152
HK - Hong Kong 137
BR - Brasile 110
VN - Vietnam 105
DE - Germania 90
BJ - Benin 68
FR - Francia 51
GB - Regno Unito 51
KR - Corea 46
CA - Canada 38
IN - India 22
BD - Bangladesh 18
AR - Argentina 16
PL - Polonia 16
UA - Ucraina 15
MX - Messico 14
ES - Italia 13
JP - Giappone 13
FI - Finlandia 12
IQ - Iraq 8
MA - Marocco 8
CO - Colombia 7
LT - Lituania 7
ZA - Sudafrica 7
CR - Costa Rica 6
CZ - Repubblica Ceca 6
EC - Ecuador 6
BO - Bolivia 5
CL - Cile 5
TH - Thailandia 5
AT - Austria 4
GT - Guatemala 4
IE - Irlanda 4
SE - Svezia 4
BE - Belgio 3
GE - Georgia 3
ID - Indonesia 3
JM - Giamaica 3
PY - Paraguay 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
TR - Turchia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
HN - Honduras 2
KE - Kenya 2
KZ - Kazakistan 2
MY - Malesia 2
PH - Filippine 2
PS - Palestinian Territory 2
QA - Qatar 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GI - Gibilterra 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
LK - Sri Lanka 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
TV - Tuvalu 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.183
Città #
Amsterdam 3.746
San Jose 307
Singapore 162
Council Bluffs 158
Hong Kong 137
Ashburn 103
Los Angeles 89
Columbus 71
Cotonou 68
Beijing 56
Moscow 54
Seoul 44
Lauterbourg 41
Phoenix 38
Santa Clara 38
Munich 29
Ho Chi Minh City 27
New York 27
Novara 26
Falkenstein 24
Boardman 23
Hanoi 22
Buffalo 21
Schaumburg 18
Orem 17
Brooklyn 15
Nuremberg 15
Olathe 14
Warsaw 14
Toronto 12
London 11
Tokyo 11
Tornaco 11
Dallas 10
Helsinki 10
Boston 9
Chicago 8
Frankfurt am Main 8
Mexico City 8
Milan 8
St Louis 8
Turin 8
Vercelli 8
Atlanta 7
Haiphong 7
Montreal 7
Assago 6
Brno 6
Chennai 6
Da Nang 6
São Paulo 6
Tianjin 6
Baghdad 5
Bari 5
Calgary 5
Houston 5
San Francisco 5
San José 5
Santiago 5
Seattle 5
Cape Town 4
City of London 4
Granada 4
Grants Pass 4
Kansas City 4
Querétaro 4
Rome 4
Stockholm 4
Brussels 3
Curitiba 3
Denver 3
Dublin 3
Guangzhou 3
Guatemala City 3
Kutaisi 3
La Paz 3
Mumbai 3
Newark 3
Poplar 3
Porto Alegre 3
Redondo Beach 3
Agadir 2
Aparecida de Goiânia 2
Bang Lamung 2
Barnet 2
Biên Hòa 2
Brasília 2
Buenos Aires 2
Buttapietra 2
Bắc Ninh 2
Cagliari 2
Camaçari 2
Casablanca 2
Cavallirio 2
Charleston 2
Ciudad del Este 2
Dayton 2
Dearborn 2
Delhi 2
Doha 2
Totale 5.740
Nome #
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 1.993
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 1.989
FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy 114
Acetylation of Human Mitochondrial Citrate Carrier Modulates Citrate/Malate Exchange to Sustain NADPH Production During Macrophage Activation 101
Blockade of glutamine synthetase enhances inflammatory response 100
BLOCKADE OF GLUTAMINE SYNTHETASE SKEWS MACROPHAGES TOWARDS AN M1-LIKE PHENOTYPE AND INHIBITS TUMOR METASTASIS 95
inibitori del carrier del citrato nel trattamento dell'infiammazione 92
“The citrate-related inflammatory pathway” 86
BLOCKADE OF GLUTAMINE SYNTHETASE SKEWS MACROPHAGES TOWARDS AN M1-LIKE PHENOTYPE AND INHIBITS TUMOR METASTASIS 85
Impaired cAMP–PKA–CREB1 signalling drives mitochondrial dysfunction in skeletal muscle during cancer cachexia 80
Histamine catabolism contributes to cardiac injury by sustaining monoamine oxidase-dependent oxidative stress 80
Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells 77
Acetylation of Human Mitochondrial Citrate Carrier Modulates Citrate/Malate Exchange to Sustain NADPH Production During Macrophage Activation 77
A key role of the mitochondrial citrate carrier (SLC25A1) in TNFα- and IFNγ-triggered inflammation 76
BLOCKADE OF GLUTAMINE SYNTHETASE SKEWS MACROPHAGES TOWARDS AN M1-LIKE PHENOTYPE AND INHIBITS TUMOR METASTASIS 75
Editorial: Metabolism Meets Function: Untangling the Cross-Talk Between Signaling and Metabolism 75
Cachexia, a systemic disease beyond muscle atrophy 75
Glufosinate constrains synchronous and metachronous metastasis by promoting anti-tumor macrophages 72
Glutamine synthetase: Localization dictates outcome 71
Elements in support of the 'non-identity' of the PGRMC1 protein with the σ2 receptor 71
Glutamine synthetase desensitizes differentiated adipocytes to proinflammatory stimuli by raising intracellular glutamine levels 71
FOXD3 acts as a repressor of the mitochondrial S-adenosylmethionine carrier (SLC25A26) gene expression in cancer cells 71
ATP-citrate lyase is essential for macrophage inflammatory response 70
Editorial: Understanding how myeloid cell development and function meet tissue distinct metabolic requirements 70
Monoamine oxidase-dependent histamine catabolism accounts for post-ischemic cardiac redox imbalance and injury 69
Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3 68
Acetylation of human mitochondrial citrate carrier modulates mitochondrial citrate/malate exchange activity to sustain NADPH production during macrophage activation 68
The citrate-related inflammatory pathway 66
SLC25A26 overexpression impairs cell function via mtDNA hypermethylation and rewiring of methyl metabolism 65
The mitochondrial citrate carrier: a new player in inflammation 64
Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis 64
N-acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages 63
Mitochondrial carriers in inflammation induced by bacterial endotoxin and cytokines 61
The J2-immortalized murine macrophage cell line displays phenotypical and metabolic features of primary BMDMs in their M1 and M2 polarization state 60
SLC25A10 biallelic mutations in intractable epileptic encephalopathy with complex I deficiency 60
Impact of immunometabolism on cancer metastasis: A focus on T cells and macrophages 60
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia 59
The influence of fatty acid metabolism on T cell function in lung cancer 58
Understanding Metal Dynamics Between Cancer Cells and Macrophages: Competition or Synergism? 58
IκBα targeting promotes oxidative stress-dependent cell death 56
Pharmacological targets of metabolism in disease: Opportunities from macrophages 55
“Pharmacological Targeting of Glutamine Synthetase Skews Macrophages Toward An Inflammatory Phenotype and Inhibits Metastasis” 52
The mitochondrial citrate carrier: a new player in inflammation 51
MEF2C exon α: Role in gene activation and differentiation 48
Metabolism and TAM functions—it takes two to tango 48
The mitochondrial aspartate/glutamate carrier isoform 1 gene expression is regulated by CREB in neuronal cells 47
Insight into mechanism of in vitro insulin secretion increase induced by antipsychotic clozapine: Role of FOXA1 and mitochondrial citrate carrier 47
The contribution of the citrate pathway to oxidative stress in Down syndrome 39
The crowded crosstalk between cancer cells and stromal microenvironment in gynecological malignancies: Biological pathways and therapeutic implication 34
Mitochondrial IκBα fuels cancer progression through metabolic rewiring, endothelial activation, and thrombotic spread 31
null 23
Totale 7.240
Categoria #
all - tutte 20.451
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.451


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024200 0 0 0 0 0 0 0 0 0 0 140 60
2024/2025626 25 0 63 9 21 33 46 61 137 55 25 151
2025/20265.855 94 84 131 212 247 148 264 302 3.870 163 258 82
2026/2027559 77 191 89 202 0 0 0 0 0 0 0 0
Totale 7.240